James H. Sabry
James H. Sabry "joined the HopeLab board of directors in May 2006. He is president and chief executive officer of Arete Therapeutics, Inc., a privately-held pharmaceutical company discovering and developing first-in-class small-molecule drugs.
"Dr. Sabry is also chairman of the board of directors and former CEO of Cytokinetics, a company he co-founded in August 1997. Prior to Cytokinetics, James held faculty positions at the University of California, San Francisco, and Harvard Medical School. He has been a recipient of the Damon Runyon Walter Winchell Fellowship in Cancer Biology and a postdoctoral fellowship at Stanford University recipient and is the author of numerous scientific papers.
"James has held professional positions with the World Economic Forum in Geneva, the John F. Kennedy School of Government at Harvard, the Brigham and Women’s Hospital at Harvard, and the Mayfield Fund. He is a member of the American Society of Cell Biology, the American Heart Association, the American Society of Clinical Oncology and the Young Presidents Organization." 
Resources and articles
Related Sourcewatch articles
- James H. Sabry, HopeLab, accessed August 28, 2009.